Analysis of Medicare Prescription Drug Plans In 2012 And Key Trends Since 2006
This report presents findings from an analysis of the Medicare Part D marketplace in 2012 and changes in drug coverage and costs since 2006.
View the Latest: Medicare Part D
Filter
-
-
Medicare Part D 2012 Data Spotlights
ReportThe Kaiser Family Foundation has issued this collection of analyses related to the Medicare Part D stand-alone drug plan options available to seniors in 2012. These spotlights focuses on key aspects of the drug plan choices available and relevant trends since the Medicare drug benefit took effect in 2006.
-
The Part D Experience: What are the Lessons for Broader Medicare Reform?
Event Date:EventLaunched in 2006, Medicare added a prescription drug benefit that relies entirely on private plans, while, for other benefits, beneficiaries have a choice between private health plans and traditional fee-for-service Medicare.
-
Medicare Part D Spending Trends: Understanding Key Drivers and the Role of Competition
Issue BriefThis brief commissioned by the Foundation examines factors that contributed to Medicare's lower-than-expected spending on prescription drugs under the Medicare Part D drug benefit that started in 2006. Since its launch, Medicare has spent about 30 percent less on Part D benefits than the Congressional Budget Office originally projected.
-
Prescription Drug Procurement and the Federal Budget
Issue BriefThis brief commissioned by the Foundation considers areas where Medicare faces limited opportunity for market-based competition and price negotiation to drive down drug spending.
-
Kaiser November Health Tracking Poll: Individual Elements of the ACA Popular with the Public
PerspectiveAfter taking a negative turn in October, the public’s overall views on the Patient Protection and Affordable Care Act (ACA) returned to a more mixed status this month. Still, Americans remain somewhat more likely to have an unfavorable view of the law (44 percent) than a favorable one (37 percent).
-
Medicare Part D 2011 Data Spotlights
ReportThe Kaiser Family Foundation has issued a collection of analyses related to the Medicare Part D stand-alone drug plan options available to seniors for calendar year 2011. These spotlights focuses on key aspects of the drug plan choices available and relevant trends since the Medicare drug benefit took effect in 2006.
-
Medicare Part D Data Spotlight: A First Look at Part D Plan Offerings in 2012
ReportThis data spotlight examines the stand-alone Part D drug plan options available to Medicare beneficiaries in 2012. Medicare beneficiaries will, on average, be able to choose from 31 stand-alone Medicare Part D prescription drug plans to choose from, a new Kaiser analysis finds.
-
Analysis of Medicare Prescription Drug Plans in 2011 and Key Trends Since 2006
ReportThis report presents findings from an analysis of the Medicare Part D marketplace in 2011 and changes in drug coverage and costs since 2006.
-
Medicare Part D 2011 Data Spotlight: The Coverage Gap
ReportThis data spotlight examines the availability of gap coverage in the private Medicare Part D drug plans offered to beneficiaries in 2011, the first year of the phase-out of the gap, as required under the 2010 health reform law.